Format

Send to

Choose Destination
Ann Biol Clin (Paris). 2019 Feb 1;77(1):26-35. doi: 10.1684/abc.2018.1402.

Interest of albuminuria in nephrology, diabetology and as a marker of cardiovascular risk.

Author information

1
Service de biochimie et hormonologie, Hôpital Lapeyronie, CHRU de Montpellier, Montpellier, France, PhyMedExp, Inserm, CNRS, Université Montpellier, Département de biochimie et hormonologie, CHU de Montpellier, Montpellier, France.
2
Service de néphrologie, Hôpital de Brabois, CHU de Nancy, Vandoeuvre-lès-Nancy, France.
3
Service de néphrologie transplantation, dialyse et aphérèses, CHU de Bordeaux, Bordeaux, France, Tissue Bioengineering, U1026, Inserm, Bordeaux, France.
4
Service de néphrologie transplantation, dialyse et aphérèses, CHU de Bordeaux, Bordeaux, France.
5
L'Institut du thorax, Inserm, CNRS, Université de Nantes, Saint-Herblain, France.
6
Laboratoire de biochimie, Hôpital Laënnec, CHU de Nantes, Saint-Herblain, France.
7
Laboratoire de biochimie, CHU de Bordeaux, Bordeaux, France, Résonance magnétique des systèmes biologiques UMR5536 CNRS Université Bordeaux, Bordeaux, France.

Abstract

Albuminuria is associated with the progression of chronic kidney disease and the occurrence of cardiovascular events in patients with and without diabetes. The evolution of albuminuria appears to be associated with patient's prognosis. How exactly microalbuminuria is linked to cardiovascular risk remains unclear. This association is probably explained by endothelial dysfunction or chronic low-grade inflammation. Albuminuria/creatininuria ratio allows reduction of potential errors in urine collection. In France, the recommendations for the monitoring of albuminuria depend on the cause of albuminuria. An increase in urinary albumin excretion could signify the need for an intensive multifactorial intervention strategy and albuminuria is a relevant biological marker to monitor therapeutic effectiveness, since a reduction of albuminuria in patients, irrespective of their diabetic status, predicts reduction of cardiovascular risk.

KEYWORDS:

cardiovascular risk; chronic kidney disease; diabetes; microalbuminuria; urinary excretion of albumin

PMID:
30799295
DOI:
10.1684/abc.2018.1402
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for John Libbey Eurotext
Loading ...
Support Center